MCMedicalCodingSoftware
J1947

J1947: Injection, furosemide (furoscix), 1 mg

HCPCSActiveBETOS O1E

J1947 is a HCPCS Level II code for injection, furosemide (furoscix), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J1947

Long descriptor
Injection, furosemide (furoscix), 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, furoscix, 1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J1947

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J1947 is not quite right, the correct code is very often within a few positions of it.

  • J1939Injection, bumetanide, 0.5 mg
  • J1940Injection, furosemide, up to 20 mgterminated
  • J1941Injection, furosemide (furoscix), 20 mgterminated
  • J1942Injection, aripiprazole lauroxil, 1 mgterminated
  • J1943Injection, aripiprazole lauroxil, (aristada initio), 1 mg
  • J1944Injection, aripiprazole lauroxil, (aristada), 1 mg
  • J1945Injection, lepirudin, 50 mgterminated
  • J1946Injection, furosemide (lasix onyu), 1 mg
  • J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
  • J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
  • J1952Leuprolide injectable, camcevi, 1 mg
  • J1953Injection, levetiracetam, 10 mgterminated
  • J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
  • J1955Injection, levocarnitine, per 1 gm
  • J1956Injection, levofloxacin, 250 mg
  • J1957Injection, levetiracetam, 5 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026